A mobile health intervention for youth with substance abuse and related issues
Official title: Adolescent Screening and Personalized Intervention Resource for Mild/Moderate Substance Abuse and Co-Occurring Problems
Funded at Oregon Research Institute · NIH-10832027 · Data updated 2026-11-12
This study is testing a new mobile app called ePACE that helps young people in the juvenile justice system who are dealing with substance use and other challenges, giving them personalized support and choices to improve their health and well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Research Institute NIH-funded |
| Lab location | 1 site (Springfield, UNITED STATES) |
| Project start | June 1, 2022 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $79,300 |
| NIH project number | 5R34DA053660-03 |
| Project ID | NIH-10832027 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents involved in the juvenile justice system who are struggling with mild to moderate substance abuse and co-occurring mental health problems.
✕Less likely to help
Patients who are not involved in the juvenile justice system or do not have substance abuse issues may not benefit from this research.
What this research studies
This research aims to develop and test a mobile health intervention designed specifically for youth involved in the juvenile justice system who are experiencing substance use and co-occurring problems. The intervention, called ePACE, will utilize technology to provide personalized feedback and allow youth to make choices about their care, promoting engagement and empowerment. By integrating behavioral health resources into a user-friendly mobile platform, the project seeks to improve access to care and clinical outcomes for these young individuals. The approach is innovative as it shifts from traditional service models to a more interactive and youth-centered method.
Why it matters
Potential benefit: If successful, this research could provide a scalable and accessible tool for youth to manage substance use and related mental health issues effectively.
How similar studies have gone: Other research has shown success with technology-based interventions for behavioral health, indicating a promising avenue for this approach.
Where this research is happening
-
Oregon Research Institute
Springfield, United States Active
Researchers
- Principal investigator: Waldron, Holly Barrett — Oregon Research Institute
- Study coordinator: Waldron, Holly Barrett
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
Neurobiological signs of resilience and recovery from substance abuse in youth who faced childhood adversity
A long-term study will explore brain patterns in young people who faced childhood adversity to understand why some stay resilient and avoid substance problems.
-
Illuminating how brain peptides control withdrawal in methamphetamine use
A new NIH grant aims to build precise chemical tools to turn brain peptide signals on or off, helping people who are withdrawing from methamphetamine.
-
Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIV
A new project will explore how HIV and methamphetamine together cause brain inflammation, with the goal of understanding why some people living with HIV experience neurocognitive problems.
-
How neighborhood stigma and support relate to substance use and HIV risk for Black and Latino bisexual men
This project looks at how local stigma and supportive places in daily life relate to substance use and HIV risk among Black and Latino bisexual men.
-
How methamphetamine and immune signals affect the brain in people with HIV
This project tests whether methamphetamine together with HIV turns on a specific immune alarm pathway (cGAS/STING) in brain cells of people living with HIV who use methamphetamine.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.